 This study will evaluate the use of radiolabeled particulate cholesterol administered intravenously in association with albumin, as a method to study reverse cholesterol transport RCT in humans by analyzing changes in the tracer activity in total plasma and lipoproteins. The study population is healthy volunteers. 